Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo

British Journal of Cancer

Volumn 80, Issue 9, 1999, Pages 1420-1426

  Hazama, S ^a   Noma, T ^a   Wang, F ^a   Iizuka, N ^a   Ogura, Y ^a   Yoshimura, K ^a   Inoguchi, E ^b   Hakozaki, M ^b   Hirose, K ^b   Suzuki, T ^a   Oka, M ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Gene therapy; IL 15; In vivo animal models; Tumour immunity; Vaccination

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 15;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENE TRANSFER; GENETIC TRANSFECTION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; FEMALE; GENE THERAPY; HUMANS; INTERLEUKIN-15; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; TRANSFECTION;

EID: 0033029480     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690538     Document Type: Article

References (24)

1. Andeson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri JG, Copeland NG, Gilbert D, Jenkins NA, Valentin V, Shapiro DN, Morris SW, Park LS and Cosman D (1995) Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 270: 29862-29869
2. Armitage RJ, Macduff BM, Eisenman J, Paxton R, and Grabstein KH (1995) IL 15 has stimulatory activity for the induction of B cell proliferation and differentation. J Immunol 154: 183-490
3. Bamford RN, Bamata AP and Waldmann TA (1996) IL-15: The role of translational regulation in their expression. J Leukocyte Biol 59: 476-480
4. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K and Caligiuri MA (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cell via components of the IL-2 receptor. J Exp Med 180: 1395-1403
5. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol 149: 3627-3635
6. Colombo MP and Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 15: 48-51
7. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC and Schabel FM Jr (1975) Tumor induction relationships in development for transplantable cancers of the colon in mice for chemotherapy assay, with a note on carcinogen structure. Cancer Res 35: 2434-2439
8. DeLeo AB, Shiku H, Tukahashi T, John M and Old LY (1977) Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and allo-antigens on cultured fibroblasts and sarcoma cells: Description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med 146: 720-734
9. Gamero AM, Ussery D, Reintgen DS, Puleo CA and Djeu JY (1991) Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 55: 4988-4994
10. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D and Anderson D (1994) Utilization of the β- and γ-chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13: 2822-2830
11. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R. Cosman D, Park LS and Anderson DM (1995) Identification and cloning of a novel IL-15 binding protien that is structurally related to the α chain of the IL-2 receptor. EMBO J 14: 3654-3663
12. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM and Giri JG (1994) Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science 264: 965-968
13. Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N and Matsushima K (1995) Chemokine gene transfection into tumor cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 72: 708-713
14. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T (1995) NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 55: 652-657
15. Lebel-Binay S, Laguerre B, Quintin Colonna F, Conjeaud H, Magazin M, Miloux B, Pecceu F, Caput D. Ferrara P and Fradelizi D (1995) Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur J Immunol 25: 2340-2348
16. Lewko WM, Smith TL, Bowman DJ, Good RW and Oldham RK (1995) Interleukin-15 and the growth of tumor derived activated T cells. Cancer Biother 10: 13-20
17. Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B and Ferrini A (1997) Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol 27: 1049-1054
18. Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Sato G, Ito K and Okudaira H (1996) IL-15 promotes cytokine production of human T helper cells. J Immunol 156: 2400-2405
19. Munger W, DeJoy SQ, Jeyaseelan R Sr, Torley LW, Grabstein KH, Eisenmann J, Paxtox R, Cox RT, Wick MM and Kerwar SS (1995) Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol 165: 289-293
20. Nishimura H, Washizu J, Nakamura N, Enomoto A, and Yoshikai Y (1998) Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J Immunol 160: 936-942
21. Tokunaga K, Taniguchi H, Yoda K, Shimizu M and Sakiyama S (1986) Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 14: 2829-2829
22. Workman P, Balmain A, Hickman JA, McNally NJ, Mitchison, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC and Wallace J (1998) UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 58: 109-113
23. Wilkinson PC and Liew FY (1995) Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 181: 1255-1259
24. Zitvogel L, Tahara H, Robbins PD, Storkus, WJ, Clarke MR, Nalesnik MA and Lotze MT (1995) Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155: 1393-1403